drugset / Trial / NCT01097382

Sleep Satisfaction and Psychomotor Performance of Adults

NCT01097382

Phase 4 Completed 30 enrolled Sanofi
NaSingle-groupOpen-labelTreatment

Summary

Primary Objective: To assess sleep satisfaction before and after Zolpidem CR (Ambien CR) administration Secondary Objective: To assess Psychomotor Performance before and after Zolpidem CR (Ambien CR) administration

Timeline

Start
2010-03
Primary completion
2011-04
Completion
2011-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Zolpidem Small molecule 6.25 mg Oral
Subject Zolpidem Small molecule 12.5 mg Oral

Indications